Drug class
Antineoplastic alkylating-like cytotoxic agent; hexamethylmelamine derivative
Mechanism of action
The precise antitumour mechanism is not fully elucidated. Altretamine is a cytotoxic alkylating-like agent; metabolic activation and DNA damage are thought to contribute to inhibition of tumour-cell proliferation. The detailed mechanism should be described as incompletely established.
General use cases
- Palliative treatment of persistent or recurrent ovarian cancer after failure of a first-line cisplatin- and/or alkylating-agent-based combination regimen in the specific US product indication
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
